The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Otitis Media–Related Antibiotic Use Among Young Children in Tennessee, USA-Reference-Cited by-同舟云学术

The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Otitis Media–Related Antibiotic Use Among Young Children in Tennessee, USA

Published:2022-02-14 Issue:3 Volume:9 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Griffith Hannah¹^ORCID,Wiese Andrew D¹^ORCID,Mitchel Edward F¹,Grijalva Carlos G¹²^ORCID

Affiliation:

1. Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee, USA

2. Veterans Affairs Tennessee Valley Health Care System, Nashville, Tennessee, USA

Abstract

Abstract Otitis media (OM) is a leading cause of pediatric antibiotic use. Introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) led to reductions in OM among US children, though its impact on OM-related antibiotic use remains unclear. Among 499 683 Tennessee children <2 years of age, the OM-related antibiotic fill rate was stable after PCV13 introduction.

Funder

National Institutes of Health

National Institute on Drug Abuse

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

https://academic.oup.com/ofid/article-pdf/9/3/ofac019/42531804/ofac019.pdf

Reference28 articles.

1. Epidemiology of acute otitis media in the postpneumococcal conjugate vaccine era.;Kaur;Pediatrics,2017

2. Trends in healthcare utilization and costs associated with acute otitis media in the United States during 2008–2014.;Tong;BMC Health Serv Res,2018